ArticleScientific reports2026
Morphological and molecular identification of Fusarium wilt resistance in tomato cultivars mediated by defense gene response.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tomato is a major vegetable crop in Quetta, Balochistan, Pakistan, but its production is severely affected by Fusarium wilt caused by Fusarium oxysporium f. sp. lycopersici. The region has a continental semi-arid Mediterranean climate, which exacerbates the impact of this disease. This study aimed to identify resistance in tomato cultivars against Fusarium wilt and also understand the underlying mechanisms of host defense gene response. Sources of resistance against F. oxysporium f. sp. lycopersici in diverse tomato genotypes were identified, and expression profiling of defense genes strengthened these findings. For a comprehensive understanding of the host-pathogen interaction, the pathogen was isolated using a standard tissue isolation method. Morphological characterization revealed oval-shaped conidia of the pathogen by microscopic examination, similar to F. oxysporium f. sp. lycopersici. Molecular identification via PCR amplification of the Internal Transcribed Spacer (ITS) and Translation Elongation Factor (TEF1-α) regions supported these morphological observations and the amplified product sequence of Tom-BAC1-5 showed 99–100% similarity with the F. oxysporium f. sp. lycopersici species complex. Pathogenicity assays demonstrated that 3 cultivars (Tom/cr/pr06, Tom/cr/pr05, and Tom/cr/pr04) were highly susceptible to FOL and two cultivars (Tom/cr/pr07 and Rio Grande) were moderately resistant. The 3,3′-Diaminobenzidine DAB staining of infected tissues visually showed that highly susceptible cultivars exhibited darker staining and significant vascular damage. In contrast, moderately resistant cultivars exhibited pale staining and reduced vascular damage. Gene expression profiling further showed that these two cultivars (Tom/cr/pr07 and Rio Grande) had significantly elevated transcript levels of PR1a, WRKY33, and PAL, suggesting activation of salicylic acid signaling and phenylpropanoid biosynthesis pathways. Conversely, susceptible cultivars showed delayed or reduced expression of these defense-related genes, underscoring the importance of early transcriptional responses for effective resistance. Overall, this study highlights WRKY33 and PR1a as potential molecular markers for resistance screening and provides novel insights into the defense signaling mechanisms against F. oxysporium f. sp. lycopersici. These findings contribute to the sustainable management of Fusarium wilt and enlighten future tomato breeding programs to enhance disease resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.